4570 免疫生物研究所 企業サイト Yahooファイナンス 日経新聞 株探 四季報
基本データ
【業種】医薬品【市場】グロース（内国株式）
【決算期】3月
【会社設立】1982.9
【上場】2007.3
【直近決算日】2024-11-11
【決算予定日】
【時価総額】46億5700万円
【予想PER】40.65 倍
【PBR】3.49 倍
【自己資本比率】81.2 %
業績予想（通期のみ）
| 年度 | タイプ | 日付 | 売上高 | 営業利益 | 経常利益 | 純利益 |
|---|---|---|---|---|---|---|
| 2023-03 | 新規 | 2022-05-13 | 775 | 3 | -95 | -120 |
| 修正 | 2023-04-27 | 794(↑) | 58(↑) | -127(↓) | -289(↓) | |
| 2024-03 | 新規 | 2023-05-12 | 850 | 90 | 90 | 80 |
| 修正 | 2024-05-10 | 816(↓) | 104(↑) | 125(↑) | 186(↑) | |
| 2025-03 | 新規 | 2024-05-14 | 925 | 120 | 120 | 115 |
※来期予想のグラフはQ1と表記されているがQ4である。
| 決算期 | 四半期 | 売上高 | 営業利益 | 経常利益 | 純利益 | 1株当たり純利益 | 営業利益率 | 経常利益率 | 売上高/前年比 | 営業利益/前年比 | 経常利益/前年比 | 純利益/前年比 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 予想 | 925 | 120 | 120 | 115 | 12.97% | 12.97% | 13.3% | 15.1% | -4.3% | -38.4% | ||
| 2025-03 | 2 | 444 | 68 | 64 | 71 | 7.68 | 15.32% | 14.41% | 21.5% | 411.3% | 109.6% | 166.2% |
| 1 | 229 | 51 | 56 | 51 | 5.51 | 22.27% | 24.45% | 29.6% | ― | 318.5% | 359.9% | |
| 2024-03 | 4 | 816 | 104 | 125 | 186 | 20.05 | 12.75% | 15.32% | 2.8% | 82.5% | ― | ― |
| 3 | 548 | 10 | 25 | 20 | 2.21 | 1.82% | 4.56% | -1.2% | -43% | ― | ― | |
| 2 | 365 | 14 | 30 | 26 | 2.88 | 3.84% | 8.22% | 24.7% | ― | ― | ― | |
| 1 | 177 | 0 | 13 | 11 | 1.19 | 0% | 7.34% | 13.3% | ― | ― | ― | |
| 2023-03 | 4 | 794 | 58 | -149 | -289 | -31.1 | 7.3% | -18.77% | 22.7% | ― | ― | ― |
| 3 | 554 | 18 | -67 | -76 | -8.2 | 3.25% | -12.09% | 23.8% | ― | ― | ― | |
| 2 | 293 | -54 | -129 | -136 | -14.62 | -18.43% | -44.03% | 15.4% | ― | ― | ― | |
| 1 | 156 | -14 | -54 | -58 | -6.32 | -8.97% | -34.62% | 25% | ― | ― | ― | |
| 2022-03 | 4 | 647 | -122 | -243 | -258 | -27.78 | -18.86% | -37.56% | 7.4% | ― | ― | ― |
| 3 | 448 | -136 | -232 | -243 | -26.14 | -30.36% | -51.79% | 8.1% | ― | ― | ― | |
| 2 | 253 | -136 | -188 | -199 | -21.4 | -53.75% | -74.31% | 2.4% | ― | ― | ― | |
| 1 | 125 | -73 | -101 | -110 | -11.89 | -58.4% | -80.8% | 7.3% | ― | ― | ― | |
| 2021-03 | 4 | 602 | -240 | -310 | -318 | -34.23 | -39.87% | -51.5% | 4.5% | ― | ― | ― |
| 3 | 414 | -230 | -299 | -303 | -32.61 | -55.56% | -72.22% | 6.3% | ― | ― | ― | |
| 2 | 247 | -177 | -227 | -230 | -24.75 | -71.66% | -91.9% | 7.4% | ― | ― | ― | |
| 1 | 116 | -101 | -127 | -129 | -13.85 | -87.07% | -109.48% | 2.9% | ― | ― | ― | |
| 2020-03 | 4 | 576 | -595 | -678 | -668 | -76 | -103.3% | -117.71% | -26.2% | ― | ― | ― |
| 3 | 389 | -298 | -350 | -337 | -38.67 | -76.61% | -89.97% | -32.6% | ― | ― | ― | |
| 2 | 230 | -209 | -252 | -254 | -29.18 | -90.87% | -109.57% | -40% | ― | ― | ― | |
| 1 | 113 | -104 | -127 | -124 | -14.28 | -92.04% | -112.39% | -34% | ― | ― | ― | |
| 2019-03 | 4 | 781 | -173 | -155 | -167 | -19.82 | -22.15% | -19.85% | 3% | ― | ― | ― |
| 3 | 578 | -65 | -62 | -76 | -9.03 | -11.25% | -10.73% | 14.6% | ― | ― | ― | |
| 2 | 384 | -37 | -32 | -45 | -5.4 | -9.64% | -8.33% | 15.3% | ― | ― | ― |